BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 85 filers reported holding BEAM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,995,836 | -2.3% | 124,567 | +29.7% | 0.00% | 0.0% |
| Q2 2023 | $3,066,717 | +28.3% | 96,045 | +23.0% | 0.00% | +50.0% |
| Q1 2023 | $2,390,534 | -17.7% | 78,071 | +5.1% | 0.00% | -33.3% |
| Q4 2022 | $2,904,542 | +5.4% | 74,266 | +28.3% | 0.00% | 0.0% |
| Q3 2022 | $2,757,000 | +31.5% | 57,868 | +6.9% | 0.00% | +50.0% |
| Q2 2022 | $2,096,000 | -19.1% | 54,143 | +19.7% | 0.00% | 0.0% |
| Q1 2022 | $2,591,000 | -40.2% | 45,224 | -16.8% | 0.00% | 0.0% |
| Q4 2021 | $4,333,000 | -75.1% | 54,373 | -72.8% | 0.00% | -80.0% |
| Q3 2021 | $17,402,000 | +366.5% | 199,983 | +590.3% | 0.01% | +400.0% |
| Q2 2021 | $3,730,000 | +95.8% | 28,969 | +21.7% | 0.00% | +100.0% |
| Q1 2021 | $1,905,000 | -60.3% | 23,801 | -59.5% | 0.00% | -50.0% |
| Q4 2020 | $4,794,000 | +2099.1% | 58,728 | +565.8% | 0.00% | – |
| Q3 2020 | $218,000 | – | 8,821 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
| HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
| DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
| Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
| Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
| Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
| HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
| Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
| ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
| BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |